Iht Wealth Management, LLC Protalix Bio Therapeutics, Inc. Transaction History

Iht Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$2.0 - $3.36 $4,000 - $6,720	2,000 Added 7.46%	28,800 $57,000
Q4 2022 Feb 14, 2023	BUY	$1.0 - $1.37 $4,800 - $6,576	4,800 Added 21.82%	26,800 $36,000
Q2 2022 Aug 15, 2022	SELL	$1.02 - $1.56 $2,040 - $3,120	-2,000 Reduced 8.33%	22,000 $24,000
Q4 2021 Feb 14, 2022	SELL	$0.81 - $1.33 $7,452 - $12,236	-9,200 Reduced 27.71%	24,000 $20,000
Q3 2021 Nov 15, 2021	BUY	$1.31 - $1.87 $43,492 - $62,084	33,200 New	33,200 $44,000

3.58M

61.1K

36.2K

Ticker PLX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,753,400
Market Cap $87.1M
Description
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...

Get notified when there are updates to the investment portfolio of Iht Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Iht Wealth Management, LLC with notifications on news.